This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2018.
Company Filing History:
1 out of 834,307 Years Active: 2018
Title: Monica Chen: Innovator in Pharmaceutical Compounds
Introduction
Monica Chen is a prominent inventor based in Moorpark, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in cancer treatment. Her innovative work has the potential to impact the lives of many patients suffering from various forms of cancer.
Latest Patents
Monica holds a patent for "Fused quinoline compounds as PI3K, mTOR inhibitors." This invention relates to compounds that can inhibit protein kinases associated with cancer. The patent outlines processes for the preparation of these compounds, pharmaceutical compositions containing them, and methods for treating disease states linked to cancers. The compounds are designed to be used as medicaments that inhibit mTOR and PI3K, showcasing their effectiveness in warm-blooded animals, including humans.
Career Highlights
Throughout her career, Monica has worked with notable companies, including Advenchen Pharmaceuticals. Her expertise in pharmaceutical development has positioned her as a valuable asset in the industry. Monica's innovative spirit and dedication to research have led her to achieve significant milestones in her field.
Collaborations
Monica has collaborated with esteemed colleagues such as Guoqing Paul Chen and Changren Yan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Monica Chen is a trailblazer in the field of pharmaceutical innovations, with a focus on developing compounds that can significantly impact cancer treatment. Her contributions and collaborations highlight her commitment to advancing medical science and improving patient outcomes.